TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Infectious Diseases
Study data from M.E. Sanders and co-authors update knowledge of clinical infectious diseases
April 1st, 2008
"Interest in probiotics is at an all-time high in the United States, driven in part by new products emerging in the market, by US researchers eager to evaluate efficacy claims rigorously, and by consumers interested in potential therapeutic and preventive health benefits. The US marketplace is a mixed bag of products, some well-defined and properly evaluated in controlled clinical studies and others with unsubstantiated claims of efficacy," researchers in the United States report. "Validation of probiotic contents in commercial products is needed to ensure consumer confidence. The term ''probiotic'' should be used only for products that meet the scientific criteria for...
Source: TB & Outbreaks Week (2008-04-01)
|
